Equities

Kelyniam Global Inc

KLYG:PKC

Kelyniam Global Inc

Actions
  • Price (USD)0.0587
  • Today's Change-0.001 / -2.17%
  • Shares traded2.00k
  • 1 Year change-26.63%
  • Beta-1.3394
Data delayed at least 15 minutes, as of May 24 2024 14:45 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kelyniam Global, Inc. is a custom design-to-build medical device manufacturing company. The Company specializes in the delivery of cranial implant technologies to neurologically dependent patients. The Company is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient’s computed tomography (CT) data, the Company’s 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its K-Plans include ke24, ke72 and kp5day. The Company’s emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours.

  • Revenue in USD (TTM)517.70k
  • Net income in USD-420.28k
  • Incorporated2005
  • Employees0.00
  • Location
    Kelyniam Global Inc97 River RdCOLLINSVILLE 06019-3246United StatesUSA
  • Phone+1 (800) 280-8192
  • Fax+1 (501) 641-2000
  • Websitehttps://kelyniam.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Remedent Inc1.13m-259.38k1.10m16.00--0.2324--0.9743-0.013-0.0130.05650.23670.14743.452.69---3.247.35-5.2012.9365.3864.60-21.9721.200.2033-0.7720.00---33.63-21.70-140.31------
Invivo Therapeutics Holdings Corp0.00-9.33m1.15m6.00--0.1288-----3.53-3.530.002.870.00----0.00-81.32-73.69-94.35-85.63------------0.00-------6.01--19.74--
SPO Global Inc838.00k-540.00k1.25m2.00------1.49-85.99-85.99131.76-476.561.76-------113.56-305.39----31.1527.31-64.44-384.85---1.45-----17.09-15.1313.03------
Escalon Medical Corp11.65m-296.71k1.30m38.00--1.26--0.1114-0.0401-0.04011.290.22592.403.757.51306,456.30-1.26-1.76-2.84-3.6744.0744.57-0.5265-0.91140.8927-1.620.1584--13.801.33760.89-17.06-19.85--
Nemaura Medical Inc0.00-10.65m1.45m36.00---------0.3787-0.37870.00-0.61690.000.00--0.00-117.49-58.18---131.96-------7,384.830.0305-1.4710.81---84.71---1.85--64.14--
Grapefruit USA Inc34.85k-4.37m1.55m9.00------44.46-0.008-0.0080.00006-0.01010.01211.310.22593,872.22-151.85-268.93-----1,304.65-10.09-12,531.68-408.870.0388-1.50-----83.9677.87-35.68------
Acutus Medical Inc7.16m-11.92m1.57m233.00------0.2189-0.4097-0.4170.2467-0.03080.07651.170.441730,746.78-12.72-46.76-16.05-56.88-43.79-89.12-166.40-773.492.22-6.781.03--136.3627.03-141.35---35.99--
Bone Biologics Corp0.00-6.10m1.66m2.00--0.4177-----23.10-23.100.003.620.00----0.00-114.93-98.31-189.37--------------0.00-------502.76------
Kelyniam Global Inc517.70k-420.28k1.80m0.00--3.36--3.47-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Aethlon Medical, Inc.574.25k-12.26m2.07m15.00--0.1399--3.60-5.03-5.030.23622.930.0369----38,283.33-78.62-75.30-92.02-84.98-----2,133.17-1,783.78----0.00--95.2130.86-15.55--106.99--
Dynatronics Corp33.60m-5.14m2.07m154.00--0.2774--0.0616-1.19-1.197.583.041.103.338.31218,173.30-14.35-6.02-19.94-8.3021.3727.33-13.07-4.550.6787-12.560.2188---8.41-8.81-19.84---5.11--
NanoVibronix Inc2.85m-3.20m2.07m10.00--0.592--0.7278-1.72-1.721.451.260.5160.368313.64285,000.00-57.98-116.16-101.17-169.3668.9850.47-112.35-570.471.38-13.470.00--203.5948.3331.88---34.02--
VirExit Technologies Inc0.00-1.80m2.28m-----------0.0932-0.1130.00-0.03670.00-------6,103.43-----------------3.66-----100.00--19.08------
Bioelectronics Corp1.61m-289.82k2.47m9.00------1.53-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Tivic Health Systems Inc1.23m-8.26m2.54m16.00--0.1043--2.07-42.45-42.452.753.930.16131.0710.8676,687.50-108.51---135.42--26.49---672.78--5.53--0.00--46.38---18.86------
Data as of May 24 2024. Currency figures normalised to Kelyniam Global Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.